SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-104145
Filing Date
2021-04-01
Accepted
2021-04-01 17:13:13
Documents
13
Period of Report
2021-03-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d136755d8k.htm   iXBRL 8-K 25824
2 EX-10.1 d136755dex101.htm EX-10.1 21130
  Complete submission text file 0001193125-21-104145.txt   180195

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA svra-20210330.xsd EX-101.SCH 3080
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE svra-20210330_lab.xml EX-101.LAB 18906
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE svra-20210330_pre.xml EX-101.PRE 11869
6 EXTRACTED XBRL INSTANCE DOCUMENT d136755d8k_htm.xml XML 3518
Mailing Address 900 S. CAPITAL OF TEXAS HIGHWAY SUITE 150 AUSTIN TX 78746
Business Address 900 S. CAPITAL OF TEXAS HIGHWAY SUITE 150 AUSTIN TX 78746 512-614-1848
Savara Inc (Filer) CIK: 0001160308 (see all company filings)

IRS No.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32157 | Film No.: 21799184
SIC: 2834 Pharmaceutical Preparations